GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: R-411 | RO-0272441
Compound class:
Synthetic organic
Comment: Valategrast (RO-0272441) is an orally available, small molecule α4 integrin inhibitor that was developed by Roche [2]. It is active at α4β1 and α4β7 integrins.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 8541 | valategrast |
Synonyms ![]() |
| R-411 | RO-0272441 |
Database Links ![]() |
|
| CAS Registry No. | 220847-86-9 (source: WHO INN record) |
| ChEMBL Ligand | CHEMBL2107792 |
| GtoPdb PubChem SID | 440816855 |
| PubChem CID | 11563636 |
| Search Google for chemical match using the InChIKey | VZVNFRFMDNFPOM-VWLOTQADSA-N |
| Search Google for chemicals with the same backbone | VZVNFRFMDNFPOM |
| Search PubMed clinical trials | valategrast |
| Search PubMed titles | valategrast |
| Search PubMed titles/abstracts | valategrast |
| UniChem Compound Search for chemical match using the InChIKey | VZVNFRFMDNFPOM-VWLOTQADSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | VZVNFRFMDNFPOM-VWLOTQADSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖|
Valategrast (links to external site)
Cat. No. HY-14190 |